Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 11:00 ET | Source: NeuroSigma, Inc.

NeuroSigma Announces New Publication Showing Real-Time Effects of External Trigeminal Nerve Stimulation (eTNS) on Brain Activity

LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, today announced a new publication in the journal Neuromodulation: Technology at the...
August 26, 2025 04:30 ET | Source: Custom Market Insights

[Latest] Global Umbilical Cord Blood Banking Market Size/Share Worth USD 51.67 Billion by 2034 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Umbilical Cord Blood Banking Market Size, Trends and Insights By Storage Type...
January 09, 2025 03:00 ET | Source: Coave Therapeutics

Coave Therapeutics lève €32 millions d'euros en série A pour accélérer le développement de ses médicaments génétiques de nouvelle génération

Le tour de table a été mené par Novo Holdings A/S et Bpifrance (dans le cadre de la stratégie d'investissement InnoBio), avec la participation d'investisseurs américains et européens, Invus et UI...
January 09, 2025 03:00 ET | Source: Coave Therapeutics

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines

Financing co-led by Novo Holdings A/S and Bpifrance (as part of the InnoBio investment strategy) and joined by leading US and EU investors Invus and UI Investissement alongside existing...
March 26, 2024 08:00 ET | Source: Healis Therapeutics

Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research

The collaboration will focus on Healis’ clinical program studying the safety and efficacy of CKDB-501A, a BoNT/A neuromodulator, for neuropsychiatry.
March 22, 2024 08:30 ET | Source: Precision Neuroscience

Precision Neuroscience Expands Clinical Research In Brain–Computer Interface

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at...
February 21, 2023 10:20 ET | Source: Persistence Market Research

Biomaterials Market Sale to hit US$ 470 Billion by 2032 and expand at a CAGR of 14.5%, says Persistence Market Research

New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The global Biomaterials Market was valued at US$ 112 Billion in 2021 and is expected to reach US$ 470 Billion by 2032. The global market for biomaterials...
November 08, 2022 10:00 ET | Source: NeuroSigma, Inc.

NeuroSigma Announces that Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD

Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in the United Kingdom Trials sponsored by the...
February 05, 2021 11:02 ET | Source: Acumen Research and Consulting

Neurorehabilitation Devices Market Value Anticipated To Reach US$ 3,476.3 Million By 2027: Acumen Research and Consulting

Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Neurorehabilitation Devices Market– Global Industry Analysis, Market Size,...
December 15, 2020 07:55 ET | Source: Karamedica, Inc.

Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy

RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...